ABCG1 is a cholesterol transporter involved in the efflux of cholesterol to HDL in reverse cholesterol transport. In the prior funding period, we discovered that mouse models of Type 2 diabetes as well as human subjects with Type 2 diabetes have decreased ABCG1 expression and function. We also uncovered an important intracellular role of ABCG1 and sterols in regulation of T cell proliferation and activation. We will extend these fundings in this new funding period to study how T cell homeostasis and activation are changed during atherosclerosis progression as well as in Type 2 diabetes. We will use a combination of studies in mice and in humans to address these questions. In collaboration with Project 3, (McNamara), we will study how Id3 regulates Tregulatory (Treg) phenotypes;in collaboration with Project 2 (Miller), we will examine how oxidized lipids influence Treg and monocyte phenotypes in atherogenesis. We will also obtain blood samples from the Human Phenotyping and Immune Cell Core to measure the cholesterol content and inflammatory phenotype of T cells isolated from subjects with atherosclerosis and/or with Type 2 diabetes. We will correlate these T cell measurements with clinically measured parameters for atherosclerosis and type 2 diabetes, such as carotid artery intima-media thickness (CIMT), hemoglobin Ale (HbAlc), and plasma lipoprotein levels. This project is directly related to the PPG theme of uncovering mechanisms contributing to the immunobiology of atherosclerosis.

Public Health Relevance

Despite significant advances in identifying immune cells that participate in atherogenesis, little is known about their mechanisms of action in the artery wall. We propose a novel mechanism by which sterols and the setting of Type 2 diabetes regulate T regulatory cell proliferation and phenotype to influence early events in atherogenesis in the vessel wall.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
La Jolla Institute
La Jolla
United States
Zip Code
Verbeek, Rutger; Boekholdt, S Matthijs; Stoekenbroek, Robert M et al. (2016) Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study. J Lipid Res 57:697-705
Yang, Xiaohong; Lee, Sang-Rok; Choi, Yun-Seok et al. (2016) Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results. J Lipid Res 57:706-13
Harmon, Daniel B; Srikakulapu, Prasad; Kaplan, Jennifer L et al. (2016) Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance. Arterioscler Thromb Vasc Biol 36:682-91
Choi, Soo-Ho; Kim, Jungsu; Gonen, Ayelet et al. (2016) MD-2 binds cholesterol. Biochem Biophys Res Commun 470:877-80
Park, Kiwon; Mikulski, Zbigniew; Seo, Goo-Young et al. (2016) The transcription factor NR4A3 controls CD103+ dendritic cell migration. J Clin Invest 126:4603-4615
Choi, Soo-Ho; Sviridov, Dmitri; Miller, Yury I (2016) Oxidized cholesteryl esters and inflammation. Biochim Biophys Acta :
Yeang, Calvin; Cotter, Bruno; Tsimikas, Sotirios (2016) Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis. Cardiovasc Drugs Ther 30:75-85
Tsimikas, Sotirios (2016) Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk. Curr Opin Endocrinol Diabetes Obes 23:157-64
Leibundgut, Gregor; Lee, Jun-Hee; Strauss, Bradley H et al. (2016) Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable angina. J Thromb Thrombolysis 41:569-80
Cheng, Hsin-Yuan; Gaddis, Dalia E; Wu, Runpei et al. (2016) Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest 126:3236-46

Showing the most recent 10 out of 188 publications